Prevymis 240 mg

Prevymis 240 mg is a medicine authorised by Swissmedic under authorisation number 66652. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 05 April 2018 and the authorisation is valid without a time limit. ATC code J05AX18 places the medicine in the group Antivirals for systemic use.

  • Dispensing category A
  • Authorisation number 66652
  • ATC J05AX18
  • Synthetic medicines
Authorisation data
Authorisation number66652
NamePrevymis 240 mg
Full namePrevymis 240 mg, Filmtabletten
Authorisation holderMSD Merck Sharp & Dohme AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ05AX18
First authorisation05 April 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Prevymis 240 mg, FilmtablettenA05 April 2018
2Prevymis 480 mg, FilmtablettenA05 April 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)J05AX1808.03.0.A
228Tablette(n)J05AX1808.03.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Prevymis 240 mg authorised in Switzerland?

Yes. Prevymis 240 mg is authorised by Swissmedic under authorisation number 66652, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Prevymis 240 mg have?

Prevymis 240 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Prevymis 240 mg?

The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com